文献速递抗菌药物管理

头孢地尼与头孢氨苄治疗尿路感染疗效比较的回顾性评价

Cefdinir vs cephalexin for the treatment of urinary tract infections: A retrospective evaluation.
PubMed 文献 · Am J Health Syst Pharm · 2024-01-01

本研究为回顾性比较研究,纳入社区健康系统急诊出院诊断为急性膀胱炎并接受头孢地尼或头孢氨苄治疗的患者,比较7天和14天治疗失败率。结果显示两组总体治疗失败率无差异,7天失败率分别为11.6%和8.3%(P=0.389),14天失败率头孢地尼20.7%高于头孢氨苄11.8%但无统计学意义(P=0.053)。结论提示两药治疗下尿路感染疗效相当。

要点

  • 头孢地尼与头孢氨苄治疗急性膀胱炎的总体治疗失败率无显著差异。
  • 14天治疗失败率头孢地尼数值上高于头孢氨苄,但差异未达统计学意义。
  • 复杂或非复杂性尿路感染亚组分析中两药治疗失败率亦无差异。

核心结论

  • 头孢地尼与头孢氨苄治疗下尿路感染疗效相当,尽管头孢地尼治疗失败率数值上更高但无统计学差异。

研究设计与样本

  • 回顾性比较研究,纳入社区健康系统急诊出院诊断为急性膀胱炎并处方头孢地尼或头孢氨苄的患者。

主要发现

  • 7天治疗失败率头孢地尼组11.6%(n=14),头孢氨苄组8.3%(n=10),P=0.389。
  • 14天治疗失败率头孢地尼组20.7%(n=25),头孢氨苄组11.8%(n=14),P=0.053。
  • 非复杂性和复杂性尿路感染亚组分析中两组治疗失败率无差异。

临床怎么用

  • 对于急性膀胱炎患者,头孢地尼与头孢氨苄均可作为治疗选择,疗效相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Cefdinir and cephalexin are cephalosporin antibiotics commonly used in the treatment of urinary tract infections (UTIs). Their efficacy depends on achieving sufficient time with concentrations exceeding the minimum inhibitory concentration (MIC). Despite being frequently prescribed for UTIs, cefdinir has markedly lower urine penetration compared to cephalexin. It is possible that differences in pharmacokinetics could result in dissimilar efficacy between these agents; however, comparative studies of cephalosporins in UTIs are lacking. METHODS: This was a retrospective comparative study of patients discharged from emergency departments within a community health system with a diagnosis of acute cystitis who were prescribed cefdinir or cephalexin. Treatment failure rates at 7 and 14 days were compared between the 2 agents using a χ2 or Fisher's exact test, as appropriate. RESULTS: There were no differences in overall treatment failure between the cefdinir and cephalexin groups. Treatment failure at 7 days occurred in 11.6% (n = 14) of patients in the cefdinir group and 8.3% (n = 10) of patients in the cephalexin group (P = 0.389). Treatment failure at 14 days was higher for cefdinir at 20.7% (n = 25) than for cephalexin at 11.8% (n = 14), but this difference was not statistically significant (P = 0.053). There were no differences in the rate of treatment failure in subgroup analyses of uncomplicated or complicated UTIs. CONCLUSION: The results of this study suggest that cefdinir and cephalexin have comparable efficacy for the treatment of lower UTIs. While there was a numerically higher rate of treatment failure with cefdinir, there were no significant differences in treatment failure between the agents.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Lloyd A, Grey J, Fronczek C, et al. Cefdinir vs cephalexin for the treatment of urinary tract infections: A retrospective evaluation. Am J Health Syst Pharm. 2024. PMID: 38349523. doi:10.1093/ajhp/zxae026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。